387
Views
23
CrossRef citations to date
0
Altmetric
Case Reports

Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient

, , , , , , , , , & show all
Pages 626-629 | Received 06 Dec 2011, Accepted 10 Dec 2011, Published online: 21 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Navaneeth Narayanan, Christopher D Adams, David W Kubiak, Serena Cheng, Robyn Stoianovici, Leonid Kagan & Luigi Brunetti. (2019) Evaluation of treatment options for methicillin-resistant Staphylococcus aureus infections in the obese patient. Infection and Drug Resistance 12, pages 877-891.
Read now
Dario Cattaneo, Jan-Willem Alffenaar & Michael Neely. (2016) Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones. Expert Opinion on Drug Metabolism & Toxicology 12:5, pages 533-544.
Read now

Articles from other publishers (21)

Meiling Zuo, Yuxuan Sun, Xianmei Zhao, Gaoqi Xu, Nan Wang, Jingtao Chen, Liqin Zhu, Wenjie Yang & Mingfeng Zhao. (2022) Evaluating linezolid dose regimens against methicillin‐resistant Staphylococcus aureus based on renal function in populations with different body weight . Journal of Clinical Pharmacy and Therapeutics 47:12, pages 2162-2169.
Crossref
Yasuhiro Tsuji. (2021) Hospital Pharmacometrics for Optimal Individual Administration of Antimicrobial Agents for Anti-methicillin-resistant <i>Staphylococcus aureus</i> Infected Patients. Biological and Pharmaceutical Bulletin 44:9, pages 1174-1183.
Crossref
Alison L. Blackman, Praneeth Jarugula, David P. Nicolau, Sai Ho Chui, Manjari Joshi, Emily L. Heil & Mathangi Gopalakrishnan. (2021) Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue Infections. Antimicrobial Agents and Chemotherapy 65:2.
Crossref
Wenjun Zhao, Lingti Kong, Chenchen Wu & Xiaofei Wu. (2020) Prolonged infusion of linezolid is associated with improved pharmacokinetic/pharmacodynamic (PK/PD) profiles in patients with external ventricular drains. European Journal of Clinical Pharmacology 77:1, pages 79-86.
Crossref
Joseph I. Boullata. 2021. Nutrition and Infectious Diseases. Nutrition and Infectious Diseases 367 410 .
Feifan Xie, Konstantinos Mantzarlis, Polychronis Malliotakis, Vasileios Koulouras, Sophie Degroote, Despoina Koulenti, Stijn Blot, Koen Boussery, Jan Van Bocxlaer, Pieter Colin, Epameinondas Zakynthinos, Dimitrios Georgopoulos, Athanasios Papathanasiou, Kostoula Arvaniti, Dimitrios Matamis, Anna Spring, Vasileios Bekos, Apostolos Komnos, Tilemachos Zafeiridis & Dirk Vogelaers. (2019) Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia. Journal of Antimicrobial Chemotherapy 74:3, pages 667-674.
Crossref
Nuggehally R. Srinivas. (2018) Influence of Morbid Obesity on the Clinical Pharmacokinetics of Various Anti-Infective Drugs: Reappraisal Using Recent Case Studies—Issues, Dosing Implications, and Considerations. American Journal of Therapeutics 25:2, pages e224-e246.
Crossref
Maya Hites & Fabio Silvio Taccone. 2018. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill 47 72 .
Alicia Galar, Maricela Valerio, Patricia Muñoz, Luis Alcalá, Xandra García-González, Almudena Burillo, María Sanjurjo, Santiago Grau & Emilio Bouza. (2017) Systematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact. Antimicrobial Agents and Chemotherapy 61:10.
Crossref
Young Lee. (2016) Linezolid for Methicillin-Resistant Staphylococcus aureus Pneumonia: The Impact of Obesity on Clinical Outcomes. Journal of Pharmacy & Pharmaceutics 3:2, pages 1-4.
Crossref
Syed Tabish R. Zaidi & Brett Janson. 2016. Drug Dosing in Obesity. Drug Dosing in Obesity 63 76 .
Silvia Corcione, Nicole Pagani, Lorena Baietto, Vito Fanelli, Rosario Urbino, V. Marco Ranieri, Giovanni Di Perri, Antonio D'Avolio & Francesco G. De Rosa. (2015) Pharmacokinetics of high dosage of linezolid in two morbidly obese patients. Journal of Antimicrobial Chemotherapy 70:8, pages 2417-2418.
Crossref
M. Hites & F. S. Taccone. (2015) Optimization of antibiotic therapy in the obese, critically ill patientOptimisation de l’antibiothérapie chez le patient obèse en réanimation. Réanimation 24:3, pages 278-294.
Crossref
Gennaro De Pascale, Serena Fortuna, Mario Tumbarello, Salvatore Lucio Cutuli, MariaSole Vallecoccia, Teresa Spanu, Giuseppe Bello, Luca Montini, Mariano Alberto Pennisi, Pierluigi Navarra & Massimo Antonelli. (2014) Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration. Intensive Care Medicine 41:1, pages 103-110.
Crossref
C. E. Tucker, A. M. Lockwood & N. H. Nguyen. (2014) Antibiotic dosing in obesity: the search for optimum dosing strategies. Clinical Obesity, pages n/a-n/a.
Crossref
B. Edwards, R. Andini, S. Esposito, P. Grossi, D. Lew, T. Mazzei, A. Novelli, A. Soriano & I.M. Gould. (2014) Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?. Journal of Global Antimicrobial Resistance 2:3, pages 133-140.
Crossref
Joseph I. Boullata. (2014) Comments on Linezolid in Morbid Obesity. Annals of Pharmacotherapy 48:3, pages 429-429.
Crossref
Ursula Theuretzbacher. 2014. Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics. Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics 401 443 .
Amira A. Bhalodi, Pavlos K. Papasavas, Darren S. Tishler, David P. Nicolau & Joseph L. Kuti. (2013) Pharmacokinetics of Intravenous Linezolid in Moderately to Morbidly Obese Adults. Antimicrobial Agents and Chemotherapy 57:3, pages 1144-1149.
Crossref
R. Hamilton, X. C. Thai, D. Ameri & M. P. Pai. (2012) Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects?. Journal of Antimicrobial Chemotherapy 68:3, pages 666-673.
Crossref
Brett Janson & Karin Thursky. (2012) Dosing of antibiotics in obesity. Current Opinion in Infectious Diseases 25:6, pages 634-649.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.